Sharba Tasneem

544 total citations
11 papers, 439 citations indexed

About

Sharba Tasneem is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Sharba Tasneem has authored 11 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 5 papers in Molecular Biology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Sharba Tasneem's work include Synthesis and biological activity (5 papers), Click Chemistry and Applications (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Sharba Tasneem is often cited by papers focused on Synthesis and biological activity (5 papers), Click Chemistry and Applications (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Sharba Tasneem collaborates with scholars based in India and Saudi Arabia. Sharba Tasneem's co-authors include Mohammad Mumtaz Alam, Mymoona Akhter, Mohammad Shaquiquzzaman, Garima Verma, Mohemmed Faraz Khan, M. Wasim Akhtar, Akranth Marella, Lalit Mohan Nainwal, Suhel Parvez and Anzarul Haque and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Medicinal Chemistry and Mini-Reviews in Medicinal Chemistry.

In The Last Decade

Sharba Tasneem

9 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharba Tasneem India 6 328 161 39 37 32 11 439
Garima Verma India 4 310 0.9× 125 0.8× 37 0.9× 36 1.0× 29 0.9× 7 399
Sarbjot Singh India 5 350 1.1× 97 0.6× 52 1.3× 43 1.2× 25 0.8× 12 469
Hermenegilda Moreno‐Díaz Mexico 8 330 1.0× 140 0.9× 45 1.2× 22 0.6× 20 0.6× 12 454
Yogesh T. Naliapara India 10 419 1.3× 115 0.7× 39 1.0× 61 1.6× 17 0.5× 41 480
K. Vinaya India 14 431 1.3× 148 0.9× 26 0.7× 47 1.3× 35 1.1× 45 538
Mateusz Daśko Poland 12 406 1.2× 206 1.3× 46 1.2× 54 1.5× 54 1.7× 30 630
Sumit S. Chourasiya India 14 382 1.2× 141 0.9× 29 0.7× 26 0.7× 42 1.3× 20 476
T. Arulmoli India 9 379 1.2× 100 0.6× 39 1.0× 28 0.8× 30 0.9× 13 466
Khursheed Ansari India 8 391 1.2× 106 0.7× 28 0.7× 35 0.9× 25 0.8× 12 468
Chinnasamy Rajaram Prakash India 13 411 1.3× 157 1.0× 38 1.0× 30 0.8× 16 0.5× 25 507

Countries citing papers authored by Sharba Tasneem

Since Specialization
Citations

This map shows the geographic impact of Sharba Tasneem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharba Tasneem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharba Tasneem more than expected).

Fields of papers citing papers by Sharba Tasneem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharba Tasneem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharba Tasneem. The network helps show where Sharba Tasneem may publish in the future.

Co-authorship network of co-authors of Sharba Tasneem

This figure shows the co-authorship network connecting the top 25 collaborators of Sharba Tasneem. A scholar is included among the top collaborators of Sharba Tasneem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharba Tasneem. Sharba Tasneem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Devi, S. Rama, et al.. (2025). Anticancer activity of hydrazones in the last quinquennial period: A special emphasis on various enzyme targets and SAR. European Journal of Medicinal Chemistry. 302(Pt 1). 118305–118305.
3.
Azam, Faizul, Mohammad Ahmed Khan, Mohammad Shaquiquzzaman, et al.. (2025). Thiazolidinedione‐Pyrimidine Hybrid as Potential Antidiabetic Agents and Their Cardioprotective Effect. Journal of Heterocyclic Chemistry. 62(9). 791–814. 1 indexed citations
4.
Alam, Mohammad Mumtaz, Faizul Azam, Mohammad Ahmed Khan, et al.. (2024). Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling. Bioorganic Chemistry. 147. 107336–107336. 6 indexed citations
5.
Tasneem, Sharba, Mohammad Mumtaz Alam, Suhel Parvez, et al.. (2023). Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer. Future Medicinal Chemistry. 15(18). 1669–1685. 1 indexed citations
6.
Iqubal, Ashif, Mohammad Ahmed Khan, Mohammad Shaquiquzzaman, et al.. (2023). Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent. Bioorganic Chemistry. 134. 106449–106449. 24 indexed citations
8.
Nainwal, Lalit Mohan, Mymoona Akhter, Asif Husain, et al.. (2021). Synthesis, and reverse screening of 6‐(3,4,5‐trimethoxyphenyl)pyrimidine‐5‐carbonitrile derivatives as anticancer agents: Part‐II. Journal of Heterocyclic Chemistry. 59(4). 771–788. 5 indexed citations
9.
Tasneem, Sharba, Mohammad Mumtaz Alam, Mohd Amir, et al.. (2021). Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics. Mini-Reviews in Medicinal Chemistry. 22(12). 1648–1706. 12 indexed citations
10.
Nainwal, Lalit Mohan, Sharba Tasneem, M. Wasim Akhtar, et al.. (2018). Green recipes to quinoline: A review. European Journal of Medicinal Chemistry. 164. 121–170. 170 indexed citations
11.
Shaquiquzzaman, Mohammad, Garima Verma, Akranth Marella, et al.. (2015). Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. European Journal of Medicinal Chemistry. 102. 487–529. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026